← Back to Search

Caspase-1 Inhibitor

Belnacasan for Coronavirus

Phase 2
Waitlist Available
Led By Glenn Wortmann, MD
Research Sponsored by MedStar Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up days 4, 7, 10, 14, 21, 28, 42, and 60 post randomization

Summary

This trial tests a pill called Belnacasan for patients with mild to moderate COVID-19. The pill aims to reduce harmful inflammation by blocking an enzyme that can cause the immune system to overreact and damage organs.

Eligible Conditions
  • Coronavirus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~days 4, 7, 10, 14, 21, 28, 42, and 60 post randomization
This trial's timeline: 3 weeks for screening, Varies for treatment, and days 4, 7, 10, 14, 21, 28, 42, and 60 post randomization for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Safety and Tolerability of Belnacasan
Secondary study objectives
Caspase-1
Changes on the WHO 9-Point Ordinal Scale
Experiences of COVID-19 Related Deterioration and Mortality
+17 more

Side effects data

From 2022 Phase 2 trial • 40 Patients • NCT05164120
10%
Chest pain
100%
80%
60%
40%
20%
0%
Study treatment Arm
Interventional
Placebo

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: InterventionalExperimental Treatment1 Intervention
900mg dose TID Administration Total: 2700mg
Group II: PlaceboPlacebo Group1 Intervention
0 mg dose TID Administration Total: 0 mg
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Belnacasan
2021
Completed Phase 2
~40

Find a Location

Who is running the clinical trial?

MedStar HealthLead Sponsor
4 Previous Clinical Trials
70,398 Total Patients Enrolled
Glenn Wortmann, MDPrincipal InvestigatorMedStar Health
1 Previous Clinical Trials
414 Total Patients Enrolled
~10 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top